The DOI matches its Crossref record.
Management of the clinically inapparent adrenal mass ("incidentaloma")
Abstract
The National Institutes of Health Consensus Development Program convened surgeons, endocrinologists, pathologists, biostatisticians, radiologists, oncologists, and other health care professionals, as well as members of the general public, to address the causes, prevalence, and natural history of clinically inapparent adrenal masses, or "incidentalomas"; the appropriate evaluation and treatment of such masses; and directions for future research. Improvements in abdominal imaging techniques have increased detection of adrenal incidentalomas, and because the prevalence of these masses increases with age, appropriate management of adrenal tumors will be a growing challenge in our aging society. To address six predetermined questions, the 12-member nonfederal, nonadvocate state-of-the-science panel heard presentations from 21 experts in adrenal incidentalomas and consulted a systematic review of medical literature on the topic provided by the Agency for Healthcare Research and Quality and an extensive bibliography developed by the National Library of Medicine. The panel recommended a 1-mg dexamethasone suppression test and measurement of plasma-free metanephrines for all patients with an adrenal incidentaloma; additional measurement of serum potassium and plasma aldosterone concentration-plasma renin activity ratio for patients with hypertension; and surgery for patients with biochemical evidence of pheochromocytoma, patients with tumors greater than 6 cm, and patients with tumors greater than 4 cm who also meet other criteria. The panel also advocated a multidisciplinary approach to managing adrenal incidentalomas. The statement is an independent report of the panel and is not a policy statement of the National Institutes of Health or the federal government.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P-cortisol >138 nmol/L following DST has been suggested for diagnosis of ACS by the National Institute of Health (21).”
From The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism (2022) · cites this paper as [21]
In the citing paper
“Currently, there is no international consensus on how ACS in patients with adrenal incidentalomas should be diagnosed, and different recommendations have been provided (1–5, 21–23).”
From The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism (2022) · cites this paper as [21]
In the citing paper
“particularly in AI patients, cortisol secretion is a continuum from completely normal to clearly increased levels, and it is highly variable in the same individual (3,22).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [3]
In the citing paper
“the reliability of almost all markers of HPA axis activity, particularly ACTH and 24-h urinary free cortisol (UFC), is low (3,14,23)”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [3]
In the citing paper
“Although this risk was reported to be low in patients with adrenal adenomas smaller than 3 cm (3)”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [3]
In the citing paper
“The difficulties in defining a protocol are related to the variability of cortisol secretion in these patients (3,22) because even a 2-yr follow-up may be too short to ascertain the presence of SH (79).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [3]
Citations
Cited by
Sorted by citations
Items 901–952 of 952
Lerário, A. M., Mohan, D. R., Giordano, T. J., & Hammer, G. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00013-7
Nebennierentumoren: Diagnostik, perioperatives Management und operative Therapie
Engelmann, S. U., Burger, M., & Mayr, R. (2023) · best practice onkologie · doi:10.1007/s11654-023-00503-x
Trandafir, A.-I., Stanciu, M., Albu, S. E., Stoian, V. R., CIOFU, I., Persu, C., Nistor, C., & Carşote, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134244
Mbaba, A. N., Abdalla, K. M., Ahmed, H. M., et al. (2023) · European Scientific Journal ESJ · doi:10.19044/esj.2023.v19n18p161
Fornara, P., & Kawan, F. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-63400-4_31
Borodavko, N., Maslova, Y., & Żukow, W. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.5281/zenodo.53160
Nebennierentumoren: Diagnostik, perioperatives Management und operative Therapie
Engelmann, S. U., Burger, M., & Mayr, R. (2023) · Die Onkologie · doi:10.1007/s00761-023-01411-z
Editorial: A year in review: discussions in adrenal endocrinology
Kraljević, I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1291582
Nebennierentumoren: Diagnostik, perioperatives Management und operative Therapie
Engelmann, S. U., Burger, M., & Mayr, R. (2023) · Die Nephrologie · doi:10.1007/s11560-023-00700-3
Ali, M., Biyabani, S. R., Cowasji, Z., & Aziz, W. (2022) · Medical Journal Of South Punjab · doi:10.61581/mjsp.vol03/01/02
Romanisio, M., Daffara, T., Pitino, R., Ferrero, A., Pizzolitto, F., Zavattaro, M., Biello, F., Gennari, A., Volpe, A., Sacchetti, G. M., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3665106/v1
A rare case of giant adrenal ganglioneuroma
Yaşar, H., Türkoğlu, M. A., Kılıç, İ., et al. (2023) · Journal of Comprehensive Surgery · doi:10.51271/jocs-0023
Keskin, Z., & Gedikli, M. A. (2024) · Troia Medical Journal · doi:10.55665/troiamedj.1397822
Mortalidade por câncer de adrenal no Brasil em homens e mulheres de 2015 a 2020
Araújo, L. M. M., Coelho, V. H. O. M., Cantarelli, J. D. P., et al. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n1-292
Nael, A. (2024) · International Journal of Clinical Case Reports and Reviews · doi:10.31579/2690-4861/385
Adrenal incidentalomas: A seven-year follow-up single-center experience
Radojković, D., Pešić, M., Radojković, M., Radenković, S., Ćirić, V. M., Ilić, I., & Stević, M. (2023) · AFMN Biomedicine · doi:10.5937/afmnai41-50244
Manharlal, T. Y., Panda, S., Tripathi, A., Sharma, S., Paul, A. S., Choudhuri, S., & Swain, S. (2024) · Urologia Journal · doi:10.1177/03915603241259881
Al‐Ibraheem, A., Abdulrahman, M., Al-Rousan, M., et al. (2024) · Indian Journal of Nuclear Medicine · doi:10.4103/ijnm.ijnm_13_24
Singaporewalla, R. M., Rao, A. D., & Lee, J. Y. (2024) · World Journal of Endocrine Surgery · doi:10.5005/jp-journals-10002-1468
Self-citationAvaliação dos tumores adrenais e análise do perfil metabólico de pacientes com incidentaloma
MONTALVÃO, P. V. G., MANGUEIRA, I. M., ALVES, G. D. M., CORDEIRO, J. V. F., Soares-Mota, M., & RAVANINI, G. D. A. G. (2024) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20243685
(2000) · Time to knit · doi:10.1016/s1634-6939(18)81632-5
(2000) · Time to knit · doi:10.1016/s1762-0953(15)60347-8
Haissaguerre, M., & Tabarin, A. (2020) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(19)83573-4
10.1016/b978-84-8086-687-3.00061-4
(2000) · Time to knit · doi:10.1016/b978-84-8086-687-3.00061-4
10.1016/b978-0-323-54940-0.00075-4
(2000) · Time to knit · doi:10.1016/b978-0-323-54940-0.00075-4
10.1016/b978-0-323-05397-6.00011-0
(2000) · Time to knit · doi:10.1016/b978-0-323-05397-6.00011-0
10.1016/b978-141603497-1.10011-9
(2000) · Time to knit · doi:10.1016/b978-141603497-1.10011-9
Čtvrtlík, F., Heřman, M., Hartmann, I., & Tichý, T. (2013) · Česká urologie · doi:10.48095/cccu2013003
Nadir Görülen Adrenal Neoplazmlar: Tek Merkez Deneyimimiz
ERKAN, S., Yabanoğlu, H., Avcı, T., Özarslan, F., Bağır, G. Ş., & Koçer, N. E. (2025) · Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi · doi:10.34087/cbusbed.1290087
CT findings of the most common adrenal tumours - pictorial essay
Čtvrtlík, F., Čivrný, J., Szász, P., Odstrčil, F., & Tüdös, Z. (2020) · Česká radiologie · doi:10.55095/cesradiol2020/031
Čtvrtlík, F., Kučera, P., Szász, P., Sedláčková, Z., Langová, K., Hartmann, I., Škarda, J., Baxa, J., Hora, M., Kočová, E., et al. (2019) · Česká radiologie · doi:10.55095/cesradiol2019/035
A Case of Adrenal Incidentaloma Treated with Hand-assisted Laparoscopic Surgery
Yamanashi, Y., NAKAI, T., Yanagida, J., Yoshida, Y., Omi, Y., Horiuchi, K., Naoko, I. T. O. U., & NAGASHIMA, Y. (2024) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.85.1596
Evaluation of Serum Neudesin Levels in Patients With Adrenal Incidentaloma
Özalp, F. R., Çolak, A., Baysoy, A., et al. (2025) · Cureus · doi:10.7759/cureus.85968
Lack, E. E., & Paal, E. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4327-8.00016-4
Satani, A. A., Lacson, R. C., Silverman, S. G., et al. (2025) · Abdominal Radiology · doi:10.1007/s00261-025-05221-2
Pal, B., Halder, A., Mallik, D., Kannaujiya, V., Gupta, K., Nandi, D., & Das, N. (2025) · Case Reports in Oncology · doi:10.1159/000549943
Incidental Adrenal Nodules and Growth Rates: A Single Centre Retrospective Cohort Study
Hu, J., Lim, R., & Bolland, M. J. (2025) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.70058
Rôle de la voie Wnt/ßcaténine dans la physiopathologie de la cortico-surrénale
Berthon, A. S. (2012) · theses.fr (ABES) · doi:10.70675/f153e745z2e77z4090zac69zb5d4866fd8bf
Bonnet-Serrano, F. (2021) · theses.fr (ABES) · doi:10.70675/022bf2ffz5b62z4303z9460z55629099aab6
Endocrine Disorders and Tumors
Santore, M. T., Clifton, M. S., & Alemayehu, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-12431-0.00072-3
Devaraja, V., Rajoo, S., Valayatham, V. M., & Hui, F. S. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.01.5143
Chongvoranond, P., Chatchomchuan, W., Wanothayaroj, E., Butadej, S., Nakasatien, S., Himathongkam, T., & Thewjitcharoen, Y. (2026) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.041.01.6239
Presentation and clinical patterns of bilateral adrenal lesions: a retrospective cohort study
Lu, H., Aggarwal, E., Hodhod, A., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag199
Uzun, Ö., Icin, B. B., Cakir, B., et al. (2026) · Clinical Endocrinology · doi:10.1111/cen.70167
Protein oxidation, glycation, and carbamylation in patients with adrenal masses
Choromańska, B., Myśliwiec, P., Lewoc, M., Dadan, J., Choromańska, K., Zalewska, A., Matulewicz, M., Żendzian‐Piotrowska, M., & Maciejczyk, M. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1811270
Meola, M. (2026) · Springer eBooks · doi:10.1007/978-3-032-24767-4_28
Zhao, P., Zhu, F., Yan, C., Niu, Z., He, L., Xie, Z., & Wang, J. (2026) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2026.1915569
Liu, N. M., Woods, A. L., Carney, B. W., Jiang, Y., Abidi, H. H., Graves, C. E., & Campbell, M. J. (2026) · Journal of Surgical Research · doi:10.1016/j.jss.2026.08.021
Matteotti, R., Milone, L., Canter, D. J., & Gagner, M. (2011) · Springer eBooks · doi:10.1007/978-3-540-45021-4_29
Multi-Year Observation of Lung Cancer Metastases to the Adrenal Glands
Chorąży, M., Majcher, M., Urbanowicz, K. F., & Kwiatkowski, R. (2013) · Journal of Materials Science and Engineering B · doi:10.17265/2161-6221/2013.06.010
Metadata
- Authors
- Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., Schlechte, J. A., & Wieand, H. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Grumbach, Melvin M.
- ORCID
- Schlechte, Janet A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2003-03-04
- Volume
- 138
- Issue
- 5
- Pages
- 424-429
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2148626383
- Cited by
- 945
- References
- 0
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 21 · 2023: 26 · 2022: 25 · 2021: 44 · 2020: 40 · 2019: 31 · 2018: 35 · 2017: 45 · 2016: 39 · 2015: 55 · 2014: 58 · 2013: 48 · 2012: 54
- FWCI
- 33.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal incidentaloma, adrenal tumors, dexamethasone suppression test, plasma free metanephrines, aldosterone, renin-aldosterone system, hypertension, pheochromocytoma, surgical management, tumor size, multidisciplinary management, natural history (disease)
- MeSH terms
- Adrenal Gland Neoplasms, Biopsy, Needle, Diagnostic Imaging, Humans, Pheochromocytoma, Prevalence, Clinical Chemistry Tests
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review